Last reviewed · How we verify
NCT05993845
Modeling and Workflow Recognition for the Anterior Approach in Total Hip Arthroplasty
trial testing Recording of total hip arthroplasty in Hip Prosthesis in 60 participants. Currently enrolling.
30 June 2025
Quick facts
| Lead sponsor | Philipp Fürnstahl |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 60 |
| Start date | 30 October 2024 |
| Primary completion | 30 June 2025 |
| Estimated completion | 30 December 2025 |
| Sites | 3 locations across Switzerland |
Drugs / interventions tested
- Recording of total hip arthroplasty
Conditions studied
- Hip Prosthesis — all drugs for Hip Prosthesis →
Sponsor
Philipp Fürnstahl
Who can join
18 and older, any sex, with Hip Prosthesis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to create a systematic and general description of the surgical process for the direct anterior approach (DAA) in total hip arthroplasty (THA). For this purpose a surgical process model with a labeled dataset of THA surgery videos will be segmented into the individual surgical steps and sub-steps using a systematic approach.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05993845
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Philipp Fürnstahl trials
Trials by the same sponsor.
- NCT05904418 — Robot-Assisted US-Based Vertebral Segmentation for Pedicle Screw Trajectory Identification · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05993845 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Philipp Fürnstahl
- Last refreshed: 23 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05993845.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing